213 related articles for article (PubMed ID: 22668241)
1. Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.
Berendsen S; Broekman M; Seute T; Snijders T; van Es C; de Vos F; Regli L; Robe P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1391-415. PubMed ID: 22668241
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid for the treatment of pediatric malignant glioma.
Driever PH; Knüpfer MM; Cinatl J; Wolff JE
Klin Padiatr; 1999; 211(4):323-8. PubMed ID: 10472571
[TBL] [Abstract][Full Text] [Related]
3. Effect of valproic acid on the outcome of glioblastoma multiforme.
Tsai HC; Wei KC; Tsai CN; Huang YC; Chen PY; Chen SM; Lu YJ; Lee ST
Br J Neurosurg; 2012 Jun; 26(3):347-54. PubMed ID: 22168970
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of the valproic acid effects on glioma cells.
Hoja S; Schulze M; Rehli M; Proescholdt M; Herold-Mende C; Hau P; Riemenschneider MJ
Oncotarget; 2016 Sep; 7(39):62989-63002. PubMed ID: 27556305
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
6. New perspectives of valproic acid in clinical practice.
Činčárová L; Zdráhal Z; Fajkus J
Expert Opin Investig Drugs; 2013 Dec; 22(12):1535-47. PubMed ID: 24160174
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
8. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain.
Osuka S; Takano S; Watanabe S; Ishikawa E; Yamamoto T; Matsumura A
Neurol Med Chir (Tokyo); 2012; 52(4):186-93. PubMed ID: 22522328
[TBL] [Abstract][Full Text] [Related]
10. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
11. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
12. Emerging targeted therapies for glioma.
Miller JJ; Wen PY
Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
[TBL] [Abstract][Full Text] [Related]
13. Evolving strategies: future treatment of glioblastoma.
Chamberlain M
Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro.
Knüpfer MM; Hernáiz-Driever P; Poppenborg H; Wolff JE; Cinatl J
Anticancer Res; 1998; 18(5A):3585-9. PubMed ID: 9858943
[TBL] [Abstract][Full Text] [Related]
15. Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro.
Knüpfer MM; Pulzer F; Schindler I; Hernaíz Driever P; Knüpfer H; Keller E
Anticancer Res; 2001; 21(1A):347-51. PubMed ID: 11299760
[TBL] [Abstract][Full Text] [Related]
16. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of MCNU for malignant brain tumors].
Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
[TBL] [Abstract][Full Text] [Related]
18. Recurrent high-grade glioma: a diagnostic and therapeutic challenge.
Walbert T; Mikkelsen T
Expert Rev Neurother; 2011 Apr; 11(4):509-18. PubMed ID: 21469924
[TBL] [Abstract][Full Text] [Related]
19. Does valproic acid affect tumor growth and improve survival in glioblastomas?
Rudà R; Pellerino A; Soffietti R
CNS Oncol; 2016; 5(2):51-3. PubMed ID: 26985579
[No Abstract] [Full Text] [Related]
20. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]